Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCESS: HX575 Epoetin Alfa vs Epogen/Procrit in Anemia of CKD
NCT01693029Phase 3Completed
- Sponsor
- Sandoz
- Start
- Sep 2012
- Primary completion
- May 2014
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin alfa in anemia, sponsored by Sandoz. Started Sep 2012; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT01693029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01693029.